for long-acting injectable (LAI) technologies through a joint proposal with the University of Connecticut’s School of Pharmacy, Department of Pharmaceutical Sciences. This project aims ...

As of September 30, 2024, the Company had approximately 116.2 million fully diluted shares outstanding based on a treasury method calculation as of that ... products to its patients and customers ...

a novel composition of testosterone and anastrozole in a long-acting, slow-release subcutaneous implant. "Our new patent for T+Ai is a critical milestone as we advance through the ongoing RECAST DCIS ...

The “senseless,” potentially gang-related shooting — which unfolded in Salaam’s district — is only the latest act of gun violence to touch Harlem youths, he said in a statement to The ...